Trial Profile
An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2022
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis; Psoriasis
- Focus Therapeutic Use
- 29 Sep 2022 Status changed from active, no longer recruiting to completed.
- 30 Jun 2021 Planned End Date changed from 1 Dec 2021 to 30 Sep 2022.
- 30 Jun 2021 Status changed from recruiting to active, no longer recruiting.